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www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMMethods: A total of 1926 patients underwent the ﬁrst SES implantation between
November 2002 and December 2006 and 651 patients underwent the ﬁrst EES im-
plantation between January 2010 and December 2010, whose target lesion revascu-
larization (TLR) were investigated by telephone follow-up, examining medical
records, and asking family physicians. The patients were stratiﬁed into 4 groups ac-
cording to their estimated glomerular ﬁltration rate (eGFR): Group I, eGFR 60 ml/
min/1.73m2 (normal renal function); Group II, eGFR ＜60 and 30 ml/min/1.73m2
(mild-moderate RI); Group III, eGFR ＜30 ml/min/1.73m2 and not on hemodialysis
(HD) (severe RI without HD); and Group IV, renal failure treated with HD (severe RI
with HD).
Results: The ﬁgure shows the cumulative incidence of TLR at 3 years in all cases and
group IV. Complete 3-year follow-up was achieved in 99.6% of SES (1919/1926) and
96.2% of EES (626/651). The cumulative incidence of TLR after EES implantation
tended to be lower than that after SES implantation in group I(log rank p< 0.001), II
(log rank p< 0.001) and III (log rank p:0.073).Conclusions: EES might reduce the cumulative incidence of TLR at long term follow
up, except for the patients with HD.
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Background: Cystatin C has emerged as a sensitive biomarker of renal function.
Early change in cystatin C based glomerular ﬁltration rate (CysC-GFR) has been
reported to predict contrast induced nephropathy (CIN). We evaluated whether
baseline and 24-h change in CysC-GFR after percutaneous cardiovascular intervention
using contrast medium (CM) can serve as a prognostic marker of CIN and cardio-
vascular mortality.
Methods: We evaluated 597 patients who underwent elective coronary (n¼357) and
peripheral (n¼240) intervention from 2010 September to 2013 August at Severance
Cardiovascular Hospital, Seoul, Korea. CIN was deﬁned as increase  25% and/or 
0.5 mg/dl in serum creatinine at 48-h after intervention compared from baseline.
Cystatin C and serum creatinine levels were measured before and at 24-h after the
procedure. Receiver operating characteristic (ROC) curve with area under the curve
(AUC) value were compared for prediction of CIN. Kaplan-Meier survival curve
analysis and Cox proportional hazards regression analysis were used to ﬁnd risk
factors of cardiovascular mortality.
Results: Increment of cystatin C level at 24-h from baseline was not able to predict
CIN. AUC value of 10, 20, and 30% increment of Cystatin C levels were 0.51, 0.53,
and 0.50, respectively. However, baseline CysC-GFR < 60 ml/min showed most
superior prediction of CIN (AUC 0.68, 95% Conﬁdence Interval 0.65 – 0.72, P<
0.0001) followed by contrast amount > 200cc (AUC 0.64, P¼0.0003), baseline
modiﬁcation of diet in renal disease (MDRD) GFR < 60 ml/min (AUC 0.63,
P¼0.0005). Although 24-h change in CIN CysC-GFR was not associated with car-
diovascular mortality, baseline CysC-GFR < 60 ml/min, baseline MDRD-GFR < 60
min/min, age  75 years were associated with increased cardiovascular mortality by
Kaplan-Meier survival curve analysis. In multivariate Cox regression analysis, only
baseline CysC-GFR < 60 was a signiﬁcant predictor of cardiovascular mortality
(hazard ratio 4.1, 95% CI 1.54 – 15.65, P¼0.0075).
Conclusions: Baseline CysC-GFR< 60 was a signiﬁcant predictor of CIN and cardiac
mortality after cardiovascular intervention and early change of cystatin C showed no
beneﬁt for CIN prediction or cardiac mortality.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/DrTCT-264
Impact of different deﬁnitions on prevalence of contrast induced nephropathy in
patients undergoing transcatheter aortic valve implantation
Stylianos A. Pyxaras1, Alexander Wolf1, Yuan Zhang1, Illkyu-Oliver Lee1,
Christoph Johann1, Thomas Schmitz1, Christoph Naber1
1Contilia Heart and Vascular Center, Essen, Germany
Background: Recently the Valve Academic Research Consortium (VARC) adopted
the Akute Kidney Injury (AKIN) system in the place of the Risk, Injury, and Failure,
Loss and End-stage kidney disease (RIFLE) system to deﬁne akute kidney injury
(AKI) following transcatheter aortic valve implantation (TAVI). In this study, we
sought to assess differences in prognostic accuracy between the two systems in our
real-world retrospective population of patients undergoing TAVI.
Methods: In the present study, 239 consecutive patients undergoing transfemoral
TAVI were prospectively enrolled. AKI was deﬁned: (1) according to the AKIN
system as a post-procedural creatinine increase of 0.3 mg/dl; or (2) according to the
RIFLE system as a post-procedural decrease of the creatinine clearance of at least 25%.
Results: Both AKIN and RIFLE system deﬁnitions were signiﬁcantly associated to
one-year mortality (binary logistic regression, respectively: (1) OR 3.2, 95%CI 1.5-
6.9, p¼0.003; and (2) OR 8.5, 95%CI 3.9-18.4, p< 0.001). However, the prognostic
accuracy of RIFLE was higher (AUC 0.704; p< 0.001) as with respect to AKIN (AUC
0.602; p¼0.037) for the primary end-point of one-year mortality.
Conclusions: In a non-selected patient population undergoing TAVI, the RIFLE system
had a higher prognostic accuracy in comparison to the currently proposedAKIN system.
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Background: The prognostic relevance of direct contrast toxicity in patients under-
going transcatheter aortic valve implantation (TAVI) remains unclear, due to the
confounding hemodynamic effect of acute left ventricular ejection fraction (LVEF)
impairment on kidney function estimation.
Methods: In the present study, 239 consecutive patients undergoing transfemoral TAVI
were prospectively enrolled. Contrast induced acute kidney injury (CI-AKI) was deﬁned
according to the VARC-2 criteria as a post-procedural creatinine increase of0.3mg/dl.
Results: While LVEF and creatinine values at admission were not signiﬁcantly
associated to CI-AKI, their interaction term signiﬁcantly deﬁned CI-AKI (p¼0.033).
The long-term survival (1.71.4 years) was signiﬁcantly lower in the CI-AKI patient
group (log-rank¼5.1, p¼0.025). In the Cox-regression multivariate model analysis
CI-AKI was an independent predictor of mortality (HR 2.2, 95%CI 1.1-4.7, p¼0.034),
along with LVEF (HR 0.97, 95%CI 0.95-0.99, p¼0.012).
Conclusions: In a non-selected patient population undergoing TAVI, CI-AKI was
conﬁrmed as an independent predictor of clinical outcome. Interestingly, only the inter-
action between LVEF and baseline creatinine values was found to determine CI-AKI.Drug-Eluting Balloons and Local Drug Delivery
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PEPCAD-DES: A randomized, multicenter, single blinded trial comparing
paclitaxel coated balloon angioplasty with plain balloon angioplasty in drug-
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Background: We evaluated the impact of paclitaxel-coated balloon angioplasty for treat-
ment of drug-eluting stent restenosis compared with uncoated balloon angioplasty alone.
Methods: In this prospective, single-blind, multicenter, trial we randomly assigned
110 patients with Instent-Restnosis of drug eluting stents to undergo treatment either
with paclitaxel coated balloon (SeQuent Please, BBraun, Melsungen) or balloon an-
gioplasty alone. Primary endpoint was in-stent late lumen loss at 6 months. Secondaryug-Eluting Balloons and Local Drug Delivery B77
